Changeflow GovPing Healthcare & Life Sciences Oxford Innovation Peptide Diagnostic Patent EP3...
Routine Rule Added Final

Oxford Innovation Peptide Diagnostic Patent EP3788375A1

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

The European Patent Office granted Patent EP3788375A1 to Oxford University Innovation Limited on April 15, 2026, covering a peptide-based diagnostic method and therapy. The patent names four inventors — IRANI, WATERS, VARLEY, and RAMBERGER — and carries multiple IPC classifications including G01N 33/564 (immunological assay), C07K 7/08 (peptides), and C07K 14/705 (receptor proteins). The patent designates all major European states including EU member countries, Switzerland, Norway, and Turkey.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.

What changed

The European Patent Office published EP3788375A1, a patent application converted to granted status, on April 15, 2026. The patent is owned by Oxford University Innovation Limited and covers a peptide-based diagnostic method and therapy, with four named inventors across three IPC classifications.

Pharmaceutical and diagnostic companies operating in Europe should review the patent's scope to assess freedom-to-operate implications in the designated states, particularly in immunological assay (G01N 33/564), peptide (C07K 7/08), and receptor protein (C07K 14/705) technology areas.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DIAGNOSTIC METHOD AND THERAPY

Publication EP3788375A1 Kind: A1 Apr 15, 2026

Applicants

Oxford University Innovation Limited

Inventors

IRANI, Sarosh R, WATERS, Patrick, VARLEY, James, RAMBERGER, Melanie

IPC Classifications

G01N 33/564 20060101AFI20191108BHEP C07K 7/08 20060101ALI20191108BHEP C07K 14/705 20060101ALI20191108BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3788375A1

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent examination IP licensing Diagnostic method
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!